Are European biopharma manufacturers ‘nearshoring’?
Experts debate whether European manufacturers are preferring domestic operations as the continent competes with Asia and the US.
Biopharmaceutical Industry
Pfizer sets sights on Summit’s bispecific in combo with its ADCs
FibroGen sells China unit to AstraZeneca for $160m
Zealand Pharma steadfastly upholds amylin-based obesity drug strategy
Bain Capital buys Mitsubishi Tanabe Pharma for $3.3bn
Roche targets continued growth after strong 2024 sales
Sage rejects Biogen’s $469m takeover bid
“Nothing to do with geopolitics”: WuXi Biologics CEO bullish in face of Biosecure
